Venture capital group and med device incubator Adventus Ventures today announced seed investments in four medical device companies.
Companies receiving funding from Irvine, Calif.-based Adventus include Allevion Therapeutics, Pressao Medical, Temari Medical and Zed Medical.
Allevion is developing a smart wearable device designed to treat essential tremor, Pressao Medical is developing a non-invasive intelligent wearable device designed to treat pre-hypertension, Temari Medical is developing a next-gen treatment for cerebral aneurysms and Zed Medical is developing an intrabody imaging and tracking guide for minimally invasive catheter-based interventions, Adventus said.
“We are pleased to continue working with Adventus Ventures supporting us with initial development and strategic guidance,” Zed Medical CEO Tom Moore said in a prepared statement.
“Temari Medical’s next generation cerebral aneurysm embolic protection system has the potential to significantly address shortcomings of current devices and providing better treatment options” Temari Medical chief medical officer Dr. Mahmood Razavi said in a prepared release.
Seed financing will help support the companies through initial development and early evaluation as they prepare for Series A funding rounds in the coming months, Adventus said.
“We are excited to be working with outstanding and talented entrepreneurs to develop new medical device companies,” Adventus Ventures founder & chair Shawn Moaddeb said in a press release.